Hassan-Zahraee M, Ye Z, Xi L, Baniecki ML, et al. Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Inflamm Bowel Dis 2021 Aug 24. pii: 6357022. doi: 10.1093.
PMID: 34427649